Menu
Back to Journals » OncoTargets and Therapy
ISSN: 1178-6930
- View all (6635)
- Volume 18, 2025 (55)
- Volume 17, 2024 (142)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Journal Articles:
- 6,635 records -
Lidocaine as a Potential Therapeutic Agent in Colorectal Cancer: A Study of Gene Expression and Prognosis
Li W, Gao W, Lu C, Ji M, Yin Y, Zhang H, Liu C, Yu C
OncoTargets and Therapy 2025, 18:737-749
Published Date: 18 June 2025
Traditional Chinese Medicine Xiaoai Jiedu Recipe Suppresses the Development of Hepatocellular Carcinoma via Regulating the microRNA-29a/Signal Transducer and Activator of Transcription 3 Axis [Retraction]
Shi Y, Kong W, Lu Y, Zheng Y
OncoTargets and Therapy 2025, 18:735-736
Published Date: 11 June 2025
Crosstalk Between EGFR and Integrin Affects Invasion and Proliferation of Gastric Cancer Cell Line, SGC7901 [Retraction]
Dan L, Jian D, Na L, Xiaozhong W
OncoTargets and Therapy 2025, 18:733-734
Published Date: 10 June 2025
IGFBP1 is One of 10 Metabolic Factors Predicting Recurrence Free Survival in Gastric Cancer and Promotes Cancer Progression via ZFX-IGFBP1 Axis
Liu H, Huang Y, Fu G, Lei B, Liu K
OncoTargets and Therapy 2025, 18:717-732
Published Date: 5 June 2025
Studying Immunogenic Cell Death in Human Colorectal Cancer Organoids
Lisandrelli R, Winkler M, Trajanoski Z, Lamberti G
OncoTargets and Therapy 2025, 18:705-715
Published Date: 6 June 2025
Lowering the Selinexor Dose within the Pomalidomide and Dexamethasone Combination Regimen Elicits Fewer Side Effects While Comparable Efficacy Against Relapsed/Refractory Multiple Myeloma
Peng L, Shan T, Zhou X, Feng Z, Qiang W, Lu J, He H, Du J
OncoTargets and Therapy 2025, 18:695-703
Published Date: 6 June 2025
MAM Domain Containing 2 (MAMDC2) Affects Invasion and Metastasis of Human Gastric Cancer
Shen J, Gao G, Liu S
OncoTargets and Therapy 2025, 18:679-693
Published Date: 26 May 2025
Validation of a Combined Prognostic Score Using Plasma Tumor DNA and Clinical Features in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Taxanes
Brighi N, Schepisi G, Conteduca V, Scarpi E, Caroli P, Matteucci F, Lolli C
OncoTargets and Therapy 2025, 18:667-677
Published Date: 23 May 2025
CXCL11: A Novel Biomarker in Colorectal Cancer as Metastasis Predictor
Wibowo R, Sribudiani Y, Lukman K, Rudiman R, Ruchimat T, Sulthana BAAS, Purnama A, Wijaya A, Primastari E, Nugraha P
OncoTargets and Therapy 2025, 18:657-665
Published Date: 14 May 2025
Risk of Residual Axillary Lymph Node Macrometastasis in Early Breast Cancer PATIENTS with One Positive Macrometastasis Sentinel Lymph Node
Liu DY, Zhu Y, Xie Q, Deng J, Chen BL
OncoTargets and Therapy 2025, 18:647-656
Published Date: 12 May 2025
lncSLERT Promotes Liver Metastasis in Colorectal Cancer by Down-Regulating HUNK Expression via RBM15-Mediated m6A Modification
Wang L, Zhao L, Liu J, Cheng P, Han M, Zheng Z
OncoTargets and Therapy 2025, 18:631-646
Published Date: 9 May 2025
Targeting the Inactive Conformation of the Epidermal Growth Factor Receptor Identifies EG31: A Novel Small Molecule Inhibitor Effective Against Normal and 5-Fluorouracil-Resistant Triple Negative Breast Cancer Cells
Otifi HM
OncoTargets and Therapy 2025, 18:617-629
Published Date: 7 May 2025
Measles Virus-Based Genetic Modifications: Progress in Hematological Malignancy Treatment
Lan S, Zhao Z, He Z
OncoTargets and Therapy 2025, 18:605-615
Published Date: 25 April 2025
Efficacy and Safety of Combined PD-1 Inhibitor with Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis [Corrigendum]
Chen K, Huang X, Chen J, Zhang S
OncoTargets and Therapy 2025, 18:603-604
Published Date: 23 April 2025
A Pyroptosis-Related LncRNA Signature for Predicting Prognosis, Immune Features and Drug Sensitivity in Ovarian Cancer
Liu PW, Liu ZY, Deng SJ, Zhang X, Wang ZB, Wu NY, Liu CS, Hu MH, Wang J, Li H
OncoTargets and Therapy 2025, 18:585-601
Published Date: 23 April 2025
Therapeutic Potential of Datopotamab Deruxtecan in the Treatment of Advanced Non-Small Cell Lung Cancer: Evidence to Date
Gogtay M, Aimalla N, Thirugnanasambandam RP, Ganti AK
OncoTargets and Therapy 2025, 18:575-584
Published Date: 23 April 2025
Based on Soluble Immune Checkpoints Constructing a Random Survival Forest Model to Predict the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Cai X, Yu L, Liu X, Yan H, Xie Y, Pu Q, Shang Z, Wu Y, Jiang T, Yang Z
OncoTargets and Therapy 2025, 18:559-573
Published Date: 19 April 2025
Research Progress of GPR137 in Malignant Tumors: A Review
Li Y, Yi Z, Li X, Wang R, Zhao M, Mi L, Zhang W, Guo R, Yan S, Song J
OncoTargets and Therapy 2025, 18:545-558
Published Date: 15 April 2025
Combination of Aumolertinib, Dabrafenib, and Trametinib for a Patient with Advanced Lung Adenocarcinoma with an Osimertinib-Induced BRAF V600E Mutation: A Case Report
Wang D, Ye W, Yin Z, Xu N, Ma J
OncoTargets and Therapy 2025, 18:539-544
Published Date: 13 April 2025
Integrated Genomic Analysis of Lung Squamous Cell Carcinoma Subtypes Characterized by Immunogenic Cell Death-Relevant Gene Signature
Wang Y, Wang S, Ding R, Zhang Z, Kong J, Xie T, Xu B, Fu L, Zhang E
OncoTargets and Therapy 2025, 18:521-537
Published Date: 11 April 2025
Management of Regorafenib-Induced Hand-Foot Skin Reaction with Topical Chinese Medicine and Urea Ointment: A Case Report and Literature Review
Liu ZN, Shen YL, Dong HJ, Tan KX, Li J, Peng YM, Cui HJ
OncoTargets and Therapy 2025, 18:509-519
Published Date: 9 April 2025
Neoadjuvant Targeted Therapy with Dacomitinib in a Stage IIIA Non-Small-Cell Lung Cancer Patient Harboring EGFR G719X: A Case Report
Li D, Liu X, Liu Y, Zhu Y, Yang D, Song J, Dai Z
OncoTargets and Therapy 2025, 18:503-507
Published Date: 5 April 2025
Anti-Tumor Effects of Gilteritinib on FLT3 Mutations: Insights into Resistance Mechanisms in Ba/F3 Cell Models
Nakazawa T, Tsuzuki H, Kawase T, Mori M, Yoshida T
OncoTargets and Therapy 2025, 18:489-501
Published Date: 3 April 2025
Waldenström Macroglobulinemia and Chronic Myelomonocytic Leukemia: Case Report and Literature Review
Pan Y, Wang Y, Wang Q
OncoTargets and Therapy 2025, 18:481-487
Published Date: 3 April 2025
Exploring Protein Expression Profiles in Lung Cancer Insufficient Microwave Ablation: Implications for Recurrence
Yan P, Yuan R, Li Z, Sun M
OncoTargets and Therapy 2025, 18:467-479
Published Date: 3 April 2025
Integrating Bulk and Single-Cell RNA Sequencing Data Reveals the Prognostic Significance of HOXC9-Related Immune Gene Signatures in Hepatocellular Carcinoma
Zhang Y, Sun H, Bo W, An Z, Li J
OncoTargets and Therapy 2025, 18:453-465
Published Date: 29 March 2025
Coumarins from Citrus aurantiifolia (Christm.) Swingle Peel with Potential Cytotoxic Activity Against MCF-7 Breast Cancer Cell Line: In Vitro and In Silico Studies
Julaeha E, Mulyawan FE, Anwar FM, Akili AWR, Permadi N, Darwati, Kurnia D, Herlina T
OncoTargets and Therapy 2025, 18:441-452
Published Date: 30 March 2025
Genomic Insights Into Early Relapsed Breast Cancer: Prognostic Challenges and Mutation Landscape
Wang Y, Zhang L, Du Y, Yan T, Yang F, Yang Y, Liu B, Xie L
OncoTargets and Therapy 2025, 18:429-439
Published Date: 29 March 2025
PCSK9 Manipulates Lipid Metabolism and the Immune Microenvironment in Cancer
Cui C, Yan A, Huang S, Chen Y, Zhao J, Li C, Wang X, Yang J
OncoTargets and Therapy 2025, 18:411-427
Published Date: 27 March 2025
Prognostic and Immunological Significance of NMNAT1 in Colorectal and Pan-Cancer Contexts
Wen L, Wang P, Zhang G, Ma Y, Li J, Chen D, Liu L, Hu H, Huang C, Yao X
OncoTargets and Therapy 2025, 18:389-410
Published Date: 25 March 2025
Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric Study
Iso H, Yomota M, Shirakura Y, Yoshinaga T, Kawai S, Narita K, Seike M, Hosomi Y
OncoTargets and Therapy 2025, 18:379-387
Published Date: 19 March 2025
Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort
Farooq A, Amin A, Bashir S, Fatima M, Hassan M, Sheikh AZ, Tahseen M, Sheikh UN, Asghar K
OncoTargets and Therapy 2025, 18:367-377
Published Date: 17 March 2025
CYP3A5 Polymorphism in Circulating Tumor Cells Confers an Increased Disease-Free Survival in DLBCL Patients Treated with R-CHOP
Cerón Maldonado R, Martínez Tovar A, Ramos Peñafiel CO, De la Cruz Rosas A, García Laguna AI, Mendoza Salas I, Martínez Murillo C, Barranco Lampón GI, Montaño Figueroa EH, Jiménez-Morales S, Olarte Carrillo I
OncoTargets and Therapy 2025, 18:355-366
Published Date: 14 March 2025
Multi-Omics Analysis Revealed That TAOK1 Can Be Used as a Prognostic Marker and Target in a Variety of Tumors, Especially in Cervical Cancer
Ning L, Li X, Xu Y, Si Y, Zhao H, Ren Q
OncoTargets and Therapy 2025, 18:335-353
Published Date: 14 March 2025
Comprehensive Treatment of Anaplastic Thyroid Cancer: A Case Report
Liu J, Chu J
OncoTargets and Therapy 2025, 18:325-333
Published Date: 10 March 2025
Patient-Derived Organoids for Guiding Neoadjuvant Chemotherapy in Bilateral Primary Breast Cancer: A Case Report
Cao M, Wang R, Cheng X, Yu H, Tong Q, Yao Y
OncoTargets and Therapy 2025, 18:319-324
Published Date: 6 March 2025
The Landscape of PARP Inhibitors in Solid Cancers
Muzzana M, Broggini M, Damia G
OncoTargets and Therapy 2025, 18:297-317
Published Date: 2 March 2025
Efficacy and Safety of Combined PD-1 Inhibitor With Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis
Chen K, Huang X, Chen J, Zhang S
OncoTargets and Therapy 2025, 18:283-296
Published Date: 26 February 2025
Profiling the Tumor Immune Microenvironment of HPV-Associated Base of Tongue Squamous Cell Carcinoma
Alahmadi RM, Awadalla M, Marraiki N, Alswayyed M, Alshehri HA, Alsahli A, Khoja HA, Khojah OT, Alahmadi RM, Farid N, Alosaimi B
OncoTargets and Therapy 2025, 18:263-281
Published Date: 20 February 2025
Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies
Sheikh KA, Amjad M, Irfan MT, Anjum S, Majeed T, Riaz MU, Jassim AY, Sharif EAM, Ibrahim WN
OncoTargets and Therapy 2025, 18:233-262
Published Date: 18 February 2025
Comprehensive Analysis Identifies Hsa_circ_0058191 as a Potential Drug Resistance Target in Multiple Myeloma
Yang H, Zhu J, Wang X
OncoTargets and Therapy 2025, 18:225-231
Published Date: 12 February 2025
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
Wang B, Shen C, Liu D, Dong Z, Lin X, Liao H
OncoTargets and Therapy 2025, 18:211-224
Published Date: 11 February 2025
Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer
Cong B, Cao X, Jiang WG, Ye L
OncoTargets and Therapy 2025, 18:199-209
Published Date: 4 February 2025
Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells
Wu D, Zhang Y, Zhang L, Xia W, Cai B, Dong F, Wu K, Cheng L, Shao M, Ma H, Hu Z, Lu H
OncoTargets and Therapy 2025, 18:179-197
Published Date: 4 February 2025
Crosstalk of SPINK4 Expression With Patient Mortality, Immunotherapy and Metastasis in Pan-Cancer Based on Integrated Multi-Omics Analyses
Cao X, Luo N, Liu X, Guo K, Deng M, Lv C
OncoTargets and Therapy 2025, 18:161-177
Published Date: 4 February 2025
Dynamic Coupling of MAPK Signaling to the Guanine Nucleotide Exchange Factor GEF-H1
Leguay K, Kent OA
OncoTargets and Therapy 2025, 18:147-159
Published Date: 25 January 2025
Exploration and Identification of Vitamin D and Related Genes as Potential Biomarkers for Colorectal Tumors
Wang L, Xu R, Wang M, Wang M, Su S, Nian Y, Chen X
OncoTargets and Therapy 2025, 18:129-145
Published Date: 22 January 2025
Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker, with an Emphasis on Cervical Cancer
Liu J, Zhang Q, He L, Hu H, Wang Y, Xie P
OncoTargets and Therapy 2025, 18:107-127
Published Date: 22 January 2025
Research Progress of NK Cells in Glioblastoma Treatment
Wu H, Liu Q, Wang F, Gao W, Zhou F, Zhao H
OncoTargets and Therapy 2025, 18:87-106
Published Date: 18 January 2025
Prognostic Value of Pretreatment Carcinoembryonic Antigen (CEA) in Rectal Cancer Treated with Preoperative Short-Course Radiotherapy with Delayed Surgery or Long-Course Radiotherapy
Lin YH, Hsu HC, Huang EY
OncoTargets and Therapy 2025, 18:73-86
Published Date: 16 January 2025